Results 131 to 140 of about 3,560 (171)

Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials. [PDF]

Biomed Rep
Shen N, Qiao J, Jiang Y, Yan J, Wu R, Yin H, Zhu S, Li J.   +7 more
europepmc   +1 more source

Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia. [PDF]

Int J Gen Med
Zhao R, Ji D, Zhou Y, Qi L, Li F.
europepmc   +1 more source

Successful Renal Transplant in End-Stage Renal Disease with Chronic Immune Thrombocytopenia using Thrombopoietin Receptor Agonists and Intravenous Immunoglobulin. [PDF]

Indian J Nephrol
Behera V, K P R, Chauhan P, Meshram A, Dhawan V, Ananthakrishnan R, Hande V.   +6 more
europepmc   +1 more source

New thrombopoietin receptor agonist: avatrombopag

Japanese Journal of Thrombosis and Hemostasis
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

New benzimidazoles as thrombopoietin receptor agonists

Bioorganic and Medicinal Chemistry Letters, 2006
A novel benzimidazole series of small-molecule thrombopoietin receptor agonists has been discovered. Herein, we discuss the preliminary exploration of structure-activity relationships within this chemotype.
Richard M Keenan
exaly   +3 more sources